What is the recovery time after stem cell therapy for Multiple Sclerosis?
A simple infusion and AHSCT have radically different recovery. AHSCT may involve conditioning, profound immune suppression and extended monitoring; a commercial same-day infusion cannot claim the same evidence. Follow the exact protocol and MS team's advice.
What the evidence shows for Multiple Sclerosis
AHSCT has been studied for selected people with highly active inflammatory MS, while its risks include those of intensive conditioning and immune suppression. NIH describes AHSCT as an experimental approach being compared with best available biologic therapy in severe relapsing MS. MSC, neural-cell and exosome proposals have different and generally earlier evidence. See the NINDS MS research overview and verify the exact protocol.
Am I a candidate? → · Multiple Sclerosis: full overview → · Multiple Sclerosis cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Multiple Sclerosis: cell-therapy evidence and registered trials
- How much does stem cell therapy for Multiple Sclerosis cost? (2026)
- Multiple Sclerosis stem cell therapy — your questions answered (2026)
- Multiple Sclerosis: cell-therapy evidence by therapy class
- MSC vs HSCT for Multiple Sclerosis: what the registries show